06 Mar 2014
Swiss team combines laser technique with mass spectrometry to visualize factors involved in cancer development.
There are many reasons why it is still difficult to treat and cure cancers. A tumor may, for instance, consist of different tumor cell subpopulations, each of which has its own profile and responds differently to therapy – or not. How a tumor then actually develops and whether metastases form depends on which signals a tumor cell receives from its environment.
The team led by Prof. Bernd Bodenmiller from the Institute of Molecular Life Sciences at the University of Zurich – in cooperation with ETH Zurich and University Hospital Zurich – has succeeded in comprehensively profiling and visualizing tumor cells from patient samples. This promising method has now been published in the journal Nature Methods.
Prof. Bernd Bodenmiller.
“With our method it is possible to obtain a comprehensive picture using a novel imaging technique that currently can simultaneously record 32 biomarkers, which we expect to increase to more than one hundred in the near future,” said Bernd Bodenmiller, the study coordinator. "Furthermore, thanks to state-of-the-art imaging, the information about the cells’ neighborhood relationships is collected and their direct impact on the cellular switch-and-control circuits can be visualized."
In the introduction to his group's Nature Methods paper, Bodenmiller commented, "We applied imaging mass cytometry to human breast cancer samples, allowing delineation of cell subpopulations and cell-cell interactions and highlighting tumor heterogeneity. Imaging mass cytometry complements existing imaging approaches. It will enable basic studies of tissue heterogeneity and function and support the transition of medicine toward individualized molecularly targeted diagnosis and therapies."
Novel imaging and laser cutting
The new technique is based on methods that are already routinely used in hospitals – with two important innovations. First, the biomarkers are visualized using pure metal isotopes instead of dyes. To do so, biomarkers on very thin tissue sections are labeled with antibodies.
Secondly, information about the cells, and their control circuits, is no longer qualitative. With the new measurement method it is possible to precisely determine which cells experience what effect and to which extent. In this way the weak points of the control system can be pinpointed and this helps in the development of new therapeutic approaches. Bodenmiller says this is the reason why it is increasingly important to understand these interactions for diagnosis and therapy.
The initial measurement results of the new biomarker technique for breast cancer investigation have revealed the heterogeneity of tumors. As a consequence of major growth, some tumors suffer from oxygen deficiency on the inside, other misuse the body’s own immune cells to drive their growth. Cell-cell interactions and cell location in the center or on the edges of the tumor also have a significant influence.
About the Author
Matthew Peach is a contributing editor to optics.org.
|Achromatic metalens focuses light regardless of polarization|
|Sofradir and ULIS to invest €150M in French Nano 2022 program|
|Eindhoven team develops hybrid data storage with optical and magnetic drives|
|Brillouin light scattering reveals mechanical properties of tumors|
|Two-color approach speeds-up 3D printing by factor of 100|
|LZH-developed LIBS system on the way to the Pacific Ocean|